This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 98/9/1219    most recent 01.RES.0000220648.80170.8bv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sbaa, E. Articles by Feron, O. Search for Related Content PubMed PubMed Citation Articles by Sbaa, E. Articles by Feron, O. Related Collections Angiogenesis Animal models of human disease Cell biology/structural biology Endothelium/vascular type/nitric oxide

(Circulation Research. 2006;98:1219.)
© 2006 American Heart Association, Inc.

Integrative Physiology

Caveolin Plays a Central Role in Endothelial Progenitor Cell Mobilization and Homing in SDF-1–Driven Postischemic Vasculogenesis

Elhem Sbaa, Julie DeWever, Philippe Martinive, Caroline Bouzin, Françoise Frérart, Jean-Luc Balligand, Chantal Dessy, Olivier Feron

From the Unit of Pharmacology and Therapeutics, University of Louvain Medical School, Brussels, Belgium.

Correspondence to Olivier Feron, UCL-FATH5349, 53 Avenue E Mounier, B-1200 Brussels, Belgium. E-mail feron{at}mint.ucl.ac.be

When neovascularization is triggered in ischemic tissues, angiogenesis but also (postnatal) vasculogenesis is induced, the latter requiring the mobilization of endothelial progenitor cells (EPC) from the bone marrow. Caveolin, the structural protein of caveolae, was recently reported to directly influence the angiogenic process through the regulation of the vascular endothelial growth factor (VEGF)/nitric oxide pathway. In this study, using caveolin-1 null mice (Cav^–/–), we examined whether caveolin was also involved in the EPC recruitment in a model of ischemic hindlimb. Intravenous infusion of Sca-1⁺ Lin^– progenitor cells, but not bone marrow transplantation, rescued the defective neovascularization in Cav^–/– mice, suggesting a defect in progenitor mobilization. The adhesion of Cav^–/– EPC to bone marrow stromal cells indeed appeared to be resistant to the otherwise mobilizing SDF-1 (Stromal cell–Derived Factor-1) exposure because of a defect in the internalization of the SDF-1 cognate receptor CXCR4. Symmetrically, the attachment of Cav^–/– EPC to SDF-1–presenting endothelial cells was significantly increased. Finally, EPC transduction with caveolin small interfering RNA reproduced this advantage in vitro and, importantly, led to a more extensive rescue of the ischemic hindlimb after intravenous infusion (versus sham-transfected EPC). These results underline the critical role of caveolin in ensuring the caveolae-mediated endocytosis of CXCR4, regulating both the SDF-1–mediated mobilization and peripheral homing of progenitor cells in response to ischemia. In particular, a transient reduction in caveolin expression was shown to therapeutically increase the engraftment of progenitor cells.

Key Words: caveolin • caveolae • postnatal vasculogenesis • endothelial progenitor cells • ischemia

This article has been cited by other articles:

				F. Desjardins, I. Lobysheva, M. Pelat, B. Gallez, O. Feron, C. Dessy, and J.-L. Balligand Control of blood pressure variability in caveolin-1-deficient mice: role of nitric oxide identified in vivo through spectral analysis Cardiovasc Res, August 1, 2008; 79(3): 527 - 536. [Abstract] [Full Text] [PDF]

				A. Caporali, E. Pani, A. J.G. Horrevoets, N. Kraenkel, A. Oikawa, G. B. Sala-Newby, M. Meloni, B. Cristofaro, G. Graiani, A. S. Leroyer, et al. Neurotrophin p75 Receptor (p75NTR) Promotes Endothelial Cell Apoptosis and Inhibits Angiogenesis: Implications for Diabetes-Induced Impaired Neovascularization in Ischemic Limb Muscles Circ. Res., July 18, 2008; 103(2): e15 - e26. [Abstract] [Full Text] [PDF]